| A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI B Zingales, SG Andrade, MRS Briones, DA Campbell, E Chiari, ... Memórias do Instituto Oswaldo Cruz 104, 1051-1054, 2009 | 1370 | 2009 |
| The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications B Zingales, MA Miles, DA Campbell, M Tibayrenc, AM Macedo, ... Infection, genetics and evolution 12 (2), 240-253, 2012 | 1118 | 2012 |
| International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients AG Schijman, M Bisio, L Orellana, M Sued, T Duffy, AM Mejia Jaramillo, ... PLoS neglected tropical diseases 5 (1), e931, 2011 | 492 | 2011 |
| Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in Chagas disease patients T Duffy, M Bisio, J Altcheh, JM Burgos, M Diez, MJ Levin, RR Favaloro, ... PLoS neglected tropical diseases 3 (4), e419, 2009 | 364 | 2009 |
| Aetiological treatment of congenital Chagas’ disease diagnosed and monitored by the polymerase chain reaction AG Schijman, J Altcheh, JM Burgos, M Biancardi, M Bisio, MJ Levin, ... Journal of Antimicrobial Chemotherapy 52 (3), 441-449, 2003 | 324 | 2003 |
| Analytical Performance of a Multiplex Real-Time PCR Assay Using TaqMan Probes for Quantification of Trypanosoma cruzi Satellite DNA in Blood Samples T Duffy, CI Cura, JC Ramirez, T Abate, NM Cayo, R Parrado, ZD Bello, ... PLoS neglected tropical diseases 7 (1), e2000, 2013 | 301 | 2013 |
| Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial F Torrico, J Gascon, L Ortiz, C Alonso-Vega, MJ Pinazo, A Schijman, ... The Lancet Infectious Diseases 18 (4), 419-430, 2018 | 293 | 2018 |
| Towards a paradigm shift in the treatment of chronic Chagas disease R Viotti, B Alarcón de Noya, T Araujo-Jorge, MJ Grijalva, F Guhl, ... Antimicrobial agents and chemotherapy 58 (2), 635-639, 2014 | 272 | 2014 |
| Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas disease JM Burgos, J Altcheh, M Bisio, T Duffy, HMS Valadares, ME Seidenstein, ... International journal for parasitology 37 (12), 1319-1327, 2007 | 268 | 2007 |
| Molecular Identification of Trypanosoma cruzi Discrete Typing Units in End-Stage Chronic Chagas Heart Disease and Reactivation after Heart Transplantation JM Burgos, M Diez, C Vigliano, M Bisio, M Risso, T Duffy, C Cura, ... Clinical Infectious Diseases 51 (5), 485-495, 2010 | 257 | 2010 |
| Amiodarone Has Intrinsic Anti-Trypanosoma cruzi Activity and Acts Synergistically with Posaconazole G Benaim, JM Sanders, Y Garcia-Marchán, C Colina, R Lira, AR Caldera, ... Journal of medicinal chemistry 49 (3), 892-899, 2006 | 253 | 2006 |
| Analytical validation of quantitative real-time PCR methods for quantification of Trypanosoma cruzi DNA in blood samples from Chagas disease patients JC Ramírez, CI Cura, O da Cruz Moreira, E Lages-Silva, N Juiz, ... The Journal of Molecular Diagnostics 17 (5), 605-615, 2015 | 234 | 2015 |
| Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation M Diez, L Favaloro, A Bertolotti, JM Burgos, C Vigliano, MP Lastra, ... American Journal of Transplantation 7 (6), 1633-1640, 2007 | 218 | 2007 |
| Trypanosoma cruzi I genotypes in different geographical regions and transmission cycles based on a microsatellite motif of the intergenic spacer of spliced-leader genes CI Cura, AM Mejía-Jaramillo, T Duffy, JM Burgos, M Rodriguero, ... International journal for parasitology 40 (14), 1599-1607, 2010 | 186 | 2010 |
| Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease. MJ Levin, E Mesri, R Benarous, G Levitus, A Schijman, P Levy-Yeyati, ... The American journal of tropical medicine and hygiene 41 (5), 530-538, 1989 | 168 | 1989 |
| New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial F Torrico, J Gascón, F Barreira, B Blum, IC Almeida, C Alonso-Vega, ... The Lancet Infectious Diseases 21 (8), 1129-1140, 2021 | 153 | 2021 |
| Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity B Zingales, MA Miles, CB Moraes, A Luquetti, F Guhl, AG Schijman, ... Memórias do Instituto Oswaldo Cruz 109 (06), 828-833, 2014 | 152 | 2014 |
| Molecular epidemiology of domestic and sylvatic Trypanosoma cruzi infection in rural northwestern Argentina MV Cardinal, MA Lauricella, LA Ceballos, L Lanati, PL Marcet, MJ Levin, ... International Journal for Parasitology 38 (13), 1533-1543, 2008 | 150 | 2008 |
| Chagas’ disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi AO Luquetti, C Ponce, E Ponce, J Esfandiari, A Schijman, S Revollo, ... Diagnostic microbiology and infectious disease 46 (4), 265-271, 2003 | 150 | 2003 |
| Sensitive and Specific Detection of Trypanosoma cruzi DNA in Clinical Specimens Using a Multi-Target Real-Time PCR Approach Y Qvarnstrom, AG Schijman, V Veron, C Aznar, F Steurer, AJ Da Silva PLoS neglected tropical diseases 6 (7), e1689, 2012 | 141 | 2012 |
